Next Article in Journal
Small Universal Bacteria and Plasmid Computing Systems
Previous Article in Journal
Separation and Quantification of Four Main Chiral Glucosinolates in Radix Isatidis and Its Granules Using High-Performance Liquid Chromatography/Diode Array Detector Coupled with Circular Dichroism Detection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of 2-Deoxybrassinosteroids Analogs with 24-nor, 22(S)-23-Dihydroxy-Type Side Chains from Hyodeoxycholic Acid

1
Departamento de Química, Universidad Técnica Federico Santa María, Avenida España 1680, Valparaíso 2340000, Chile
2
Instituto de Ciencias Químicas Aplicadas, Facultad de Ingeniería, Universidad Autónoma de Chile, Santiago 8910339, Chile
3
Laboratorio de Cristalografía, Pontificia Universidad Católica de Valparaíso, Avenida Universidad 330, Curauma, Valparaíso 2340000, Chile
*
Authors to whom correspondence should be addressed.
Submission received: 4 May 2018 / Revised: 23 May 2018 / Accepted: 26 May 2018 / Published: 29 May 2018
(This article belongs to the Section Organic Chemistry)

Abstract

:
Natural brassinosteroids are widespread in the plant kingdom and it is known that they play an important role in regulating plant growth. In this study, two new brassinosteroid analogs with shorter side chains but keeping the diol function were synthesized. Thus, the synthesis of 2-deoxybrassinosteroids analogs of the 3α-hydroxy-24-nor, 22,23-dihydroxy-5α-cholestane side chain type is described. The starting material is a derivative from hyodeoxycholic acid (4), which was obtained with an overall yield of 59% following a previously reported five step route. The side chain of this intermediate was modified by oxidative decarboxylation to get a terminal olefin at the C22-C23 position (compound 20) and subsequent dihydroxylation of the olefin. The resulting epimeric mixture of 21a, 21b was separated and the absolute configuration at the C22 carbon for the main product 21a was elucidated by single crystal X-ray diffraction analysis of the benzoylated derivative 22. Finally, lactonization of 21a through a Baeyer-Villiger oxidation of triacetylated derivative 23, using CF3CO3H/CHCl3 as oxidant system, leads to lactones 24 and 25 in 35% and 14% yields, respectively. Deacetylation of these compounds leads to 2-deoxybrassinosteroids 18 and 19 in 86% and 81% yields. Full structural characterization of all synthesized compounds was achieved using their 1D, 2D NMR, and HRMS data.

Graphical Abstract

1. Introduction

Since the discovery of brassinolide (1), a polyhydroxysteroidal hormone that regulates plant growth and development, other brassinosteroids (BRs) have been found throughout all the plant kingdom and much effort has been dedicated to the synthesis of BR analogs. Most of this work has been focused on determining the structural requirements that these compounds should possess to elicit strong biological activity [1,2,3]. For example, in Figure 1 are shown the chemical structures of 1, castasterone (2) and typhasterol (3). The latter is a natural 2-deoxybrassinosteroid that may act as important biosynthetic precursors of more active brassinosteroids [4,5,6,7].
Natural occurring BRs show a variety of structural modifications in the A/B ring, but it seems that a vicinal 22R,23R diol structural functionality in the side chain is essential for high biological activity. In recent decades, many BR analogs with structural changes on the A/B rings and/or on the side chain (shorter side chains, different oxygenated functions, spirostanic, aromatic and cyclic substituents, methyl esters, carboxylic acids) have been synthesized [8,9,10,11,12]. Surprisingly, some BR analogs with drastic structural modifications in the side chain have also shown interesting activities as plant growth regulators. Thus, the structural requirement of a side chain with a cis C-22, C-23-diol, preferentially with R, R configurations, and a C-24 methyl or ethyl substituent, seems to be contradicted by an important number of BR analogs exhibiting strong biological activities. For example, in Figure 2 are shown a series of BR analogs with 24-nor-22,23-dihydroxy-type side chains, i.e., BRs analogs with shorter side chain as compared to naturally occurring BRs.
Hyodeoxycholic acid (4) has been used in the synthesis of several BRs analogs because its structure is similar to that of active BRs and it is commercially available. Thus, compounds 58 and 89 have been synthesized from 4 following different synthetic routes [13,14]. In both cases, the modification in the side chain was achieved by decarboxylation and subsequent dihydroxylation of a terminal olefin. From these compounds only 8 and 9 were evaluated as potential neuroinflammation inhibitors [14]. On the other hand, compounds 1013 were synthesized from deoxycholic acid, bearing oxygenated functions in ring C, with 24-nor-22(S),23-dihydroxy side chain and cis A/B ring fusion [15], whereas analogues 1416 were obtained from deoxycholic acid with 11-oxo-functionalized on C ring, 24-nor-22(S),23-dihydroxy and 22(S),23-diacetoxy [16]. Interestingly, compounds 10 and 13 have shown growth promoting activity in hypocotile elongation and cothyledon expansion in a radish bioassay [17].
From the synthetic point of view, the tremendous effort dedicated to obtain a number of synthetic analogs has led to development of some convenient, effective and general methods of synthesis applicable to this compound class [18,19,20,21,22,23,24,25,26,27,28,29,30,31]. In this work, we describe the synthesis of new 2-deoxybrassinosteroid analogs bearing a shorter side chain but retaining the diol function, i.e., a 3α-hydroxy-24-nor-22,23-dihydroxy-5α-cholestane side chain type. The starting material is 17, a hyodeoxycholic acid derivative. Following this procedure two new 2-deoxybrassinosteroids analogs (compounds 18 and 19, Figure 3) have been prepared. The full structural characterization of these analogs is also given.

2. Results

The main goal of this work was to synthesize BR analogs where the main structural change was a reduction of the side alkyl chain length, as compared to brassinolide (1), but keeping the glycol function at the C22−C23 position. In the steroidal nucleus, the introduction of a glycol function at the C22−C23 position via dihydroxylation with OsO4 requires the presence of a terminal double bond. In the case of hyodeoxycholic acid (4) this can be accomplished by oxidative decarboxylation using a Pb(OAc)4/Cu(OAc)2 system. This method has been proposed to obtain terminal double bonds from carboxylic acids [32], and has been used for the degradation of bile acid side chains [33], synthesis of BR analogs [14,15,17], and specifically for decarboxylation of the side chain of hyodeoxycholic acid (4) and derivatives [34,35]. Alternatively, the carboxylic degradation reaction may be carried out using PhI(OAc)2/CuSO4 system [13,34,35,36,37,38,39,40,41,42,43,44,45]. Hyodeoxycholic acid (4) is a common starting material because it is easily available, and it has been previously used to synthesize a number of BR analogs. Related to this work, we have recently reported the synthesis of compound 17 in a five step route with an overall yield of 59% [46]. This compound will be the intermediate for the synthesis of 18 and 19 (Scheme 1).

2.1. Synthesis of Brassinosteroids Analogs

Oxidative decarboxylation of the side chain of compound 17, with the Pb(OAc)4/Cu(OAc)2 system, leads to olefin 20 in 75% yield. Formation of 20 was confirmed by 1H-NMR and 13C-NMR.
Dihydroxylation of alkene 20 with OsO4 produces an epimeric mixture of 21a and 21b in 72% yield (Scheme 1). This is an expected outcome for this reaction in steroidal nucleus with a terminal double bond at the C22−C23 position (24-nor-chol-22-ene), and the 22(S) alcohol is stereoselectively obtained [47]. Thus, epimeric mixtures have been obtained during the preparation of analogs 10, 11 and 12 (Figure 2) [15,16,17].
Integration areas of signals in the 1H-NMR spectrum of mixture 21a/21b, appearing at δH = 0.965 and 0.928 ppm, respectively, and assigned to the H-21 methyl hydrogen (CH3-C20), indicates that the major component on this mixture is the less polar glycol 21a in a ratio 7.5:1.0. Recrystallization of a mixture of 21a/21b (MeOH/Et2O = 3/1) allowed for isolation of 21a in 64.0% yield.
The stereochemistry at the C22 carbon for compound 21a was assumed to be 22(S) based on previous results reported for similar hydroxylation reactions used to obtain analogues 10, 13 and 14 (Figure 2) [15,16,17]. In order to establish the absolute configuration at C22 carbon for compound 21a, the benzoylated derivative 22 (Scheme 1) was prepared. Treatment of 21a with PhCOCl/DMAP in CH2Cl2 and pyridine led to selective esterification of C23 as the only reaction product in 94.0% yield.
Finally, the molecular and crystalline structure of derivative 22 was determined using single crystal X-ray diffraction techniques. This structure crystallizes in the orthorhombic Sohncke space group P212121. The ORTEP diagram appears in Figure 4, whereas X-ray data, bond distances and angles are given in Tables S1–S3, respectively, of the Supplementary Material.
The absolute configuration S for C22 of compound 22 cannot be reliably determined using only the Flack’s parameter value of −0.2(3), calculated by using 1169 quotients of the type [(I+) − (I)]/[(I+) + (I)] [48]. Nevertheless, the analysis of Bayesian statistics of Bijovet pairs it is a much simpler and reliable method to determine the absolute configuration for molecules that contain atoms no heavier than oxygen [49]. The resulting values for the analysis of 2386 Bijovet pairs, Hooft’s parameter y: 0.0(2); P2(true): 1.000; P2(false): 1.743 × 10−6; P3(true): 0.973; P3(false): 1.695 × 10−6 and; P3(racemic twin): 0.027, have confirmed the absolute structure for compound 22. Additionally, considering that compound 22 was synthesized using enantiopure precursors, the configurations R, S, S, S, R, S, S, R and S have also been verified for atoms C3, C5, C8, C9, C10, C13, C14, C17 and C20, respectively.
A mild saponification reaction (K2CO3/MeOH, r.t.) of glycol 21a gave the brassinosteroid analog 9 in 97% yield (Scheme 2). This compound has been previously obtained by using a different synthetic route, and its structure was determined by 1H-, 13C-NMR spectroscopy, EIMS and HRMS spectrometry. However, as the assignment of NMR signals was not performed [14] both the 1H- and 13C-NMR spectra of this compound are given in the Supplementary Material.
In order to obtain 2-deoxybrassinosteroid analogs 18 and 19 a lactone group (B-homo-7-oxa and B-homo-6-oxa) must be introduced in the B ring of 21a (Scheme 2). It is known that Baeyer-Villiger oxidation of 5α-6-keto-steroids with oxygenated substituents at 2α−3α and 3α positions occurs with regioselective control, favoring 7-oxalactone formation, when electron-withdrawing substituents (acetyl [13,35,36,37,43,50], benzoyl [36,50], tosyl [36,50], trifluoroacetyl [50] and acetonide [42] groups) are present in the C-3 position [50]. Also, the use of CF3CO3H as the oxidant agent has a marked effect upon the 6-oxa/7-oxa ratio, and can lead to preferential formation of the desired 7-oxa isomer [50]. Additionally, lactonization global yields are greater than those obtained when there are hydroxyl groups in the steroid structure [45]. For these reasons, Baeyer-Villiger oxidation of triacetylated derivative 23 instead of 21a is performed with CF3CO3H/CHCl3 as the oxidant. Similar regioselectivity has been observed in the oxidation of a series of sterols with m-CPBA/NaHCO3/CH2Cl2 system, but the rates of these reactions are very slow [50].
Standard acetylation (Ac2O/DMAP) of compound 21a (Scheme 2) leads to triacetylated derivative 23 with 97% yield.
Baeyer-Villiger oxidation of 23 with CF3CO3H/CHCl3 system produces lactones 24 and 25 with 35% and 14% yields, respectively. Finally, deacetylation reaction of lactones 24 and 25 under mild conditions (K2CO3/MeOH, at room temperature) produced the new analogs of 2-deoxy-brassinosteroids 18 and 19 with 86% and 81% yields, respectively.

2.2. Elucidation of Compound Structures

The full structure assignment of compounds 20, 21a, 9, 22, and 23 were carried out by analysis of spectroscopic data obtained from 1H-NMR, 13C-NMR, and HRMS of pure and isolated compounds.
In the 1H-NMR of compound 20 the protons H-22, Htrans-23 and Hcis-23 appear at δH = 5.66 ppm (H-22), 4.93 ppm (Htrans-23) and 4.83 ppm (Hcis-23). In the 13C-NMR the carbons C22 and C23 appear at δC = 144.89 and 111.84 ppm, respectively (Table 1). These data were consistent with those reported for a similar structure but with hydroxyl function at C-3α instead of acetyl group [14,43].
In the 1H-NMR of 21a signals appearing at chemical shifts δH = 3.79 ppm, 3.64 ppm, and 3.51 ppm are assigned to protons H-22, H-23a and H-23b, respectively. On the other hand, in the 13C-NMR spectrum, the signals at δC = 73.69 and 62.22 ppm correspond to carbinolic carbons C22 and C23, respectively (see Table 1).
The 1H-NMR of triol 9 shows signals at δH = 4.04–4.03, 3.71, 3.60, and 3.40 ppm, which are assigned to hydrogens H-3, H-22, H-23a and H-23b, respectively. In the 13C-NMR three carbinolic carbons (C22, C-3 and C23) were observed at δC = 75.19, 66.02 and 63.19 ppm, (Table 1).
The structure of derivative 22 was established mainly by 1D and 2D NMR spectroscopy. In the 1H-NMR spectrum the aromatic protons appear at δH = 8.05 (HAr-2’), 7.58 (HAr-4’), and 7.46 (HAr-3’) ppm. Additionally, two low field shifted signals at δH = 4.50 (dd, J = 11.4 and 1.7 Hz, 1H) and 4.20 (dd, J = 11.3 and 4.2 Hz, 1H) ppm correspond to H-23a and H-23b. In the 13C-NMR spectrum the signal at δC = 167.01 ppm is assigned to carbonyl of aromatic ester, whereas the signals at δC = 129.86, 129.63, 128.45 and 133.22 ppm (Table 1) are assigned to aromatic ring (each one of signals at δC = 129.63 and 128.45 ppm correspond to two symmetrical carbons of the aromatic ring). In the 2D HMBC spectrum a heteronuclear correlation at 3JH-C between H-23a (δH = 4.50 ppm) with carbonyl of aromatic ester (δC = 167.01 ppm) was observed, confirming the presence of benzoyl ester at C23 position. The structure of compounds 18, 19, 24 and 25 were mainly elucidated by analysis of data obtained from 1H, 13C, 13C DEPT-135, 2D HSQC, 2D HMBC NMR, and HRMS measurements.
For compound 24, the position of the 7-oxa lactone function was established from the 1H-NMR spectrum where a signal observed at δH = 4.13–4.04 ppm (m, 2H), was assigned to hydrogens H-7 and correlated by 2D 1H-13C HSQC with the signal at δC = 70.31 ppm (CH2-7 from 13C and 13C DEPT-135 spectra, Table 2). Additionally, important heteronuclear correlations were obtained for hydrogens H-5α and H-7 from a 2D 1H-13C HMBC spectrum, i.e., (i) H-7 shows 3JHC correlations with the signal at δC = 175.97 ppm (assigned to carbon C-6, C=O of lactone function, Table 2), and signals at δC = 58.31 ppm (assigned to carbon C-9); and 2JHC correlation with signal appearing at δC = 39.42 ppm (assigned to carbon C-8); (ii) H-5α at δH = 3.03 ppm shows 3JHC correlation with signals at δC = 14.54, and 58.31 ppm, which were assigned to carbons CH3-19 and C-9, respectively (Table 2); (iii) H-5α exhibits 2JHC correlation with signals at δC = 29.7, 36.1 and 176.0 ppm, assigned to carbons C-4, C-10 and C-6, respectively. These correlations are depicted in the 2D HMBC spectrum shown in Figure 5. These observations confirmed unequivocally the 7-oxalactone position for compound 24.
A similar analysis was performed to determine the structure of 6-oxalactone 25. Thus, in the 1H-NMR spectrum a signal at δH = 4.46 ppm was assigned to H-5α, and correlated by 2D 1H-13C HSQC with the signal at δC = 79.68 ppm (CH with impair multiplicity from DEPT-135 spectrum). Additionally, H-5α shows 2JHC correlation with signal at δC = 32.95 ppm that is assigned to carbon C-4; and 3JHC correlation with signals at δC = 11.59, 57.94 and 174.64 ppm, which are assigned to carbons CH3-19, C-9 and C-6, respectively (C=O, of lactone function, Table 2). On the other hand, the 1H-NMR signal at δH = 2.55–2.43 ppm, corresponding to H-7 (2H, m), shows 2JHC correlation with signals appearing at δC = 38.31 and 174.64 ppm, which were assigned to carbons C-8 and C-6, respectively (Table 2); and 3JHC correlation with signals at δC = 57.97 ppm, assigned to carbons C-9. These correlations are shown in the 2D HMBC spectrum in Figure 6.
Similar analyses were performed to determine the structure of compounds 18 and 19. In Figure 7 are shown parts of 1H-NMR spectra of compounds 18 and 19 where the major differences in chemical shift of protons H-5 and H-7 are observed for both molecules. For example, H-5 in compound 18 (7-oxalactone) appears at higher field (δH = 3.17 ppm) than in compound 19 (6-oxalactone) (δH = 4.60 ppm) (Figure 7). Similarly, H-7α and β in compound 18 are observed at downfield (δH = 4.08–4.07, m, 2H), while in 6-oxalactone 19 these H-atoms are displaced to high field (δH = 2.53–2.43, m, 2H) (Figure 7).

3. Materials and Methods

3.1. General Experimental Methods

All reagents were purchased from commercial suppliers, and used without further purification. Melting points were measured on a SMP3 apparatus (Stuart-Scientific, now Merck KGaA, Darmstadt, Germany) and are uncorrected. 1H-, 13C-, 13C DEPT-135, gs 2D HSQC and gs 2D HMBC NMR spectra were recorded in CDCl3 or MeOD solutions, and are referenced to the residual peaks of CHCl3 at δ = 7.26 ppm and δ = 77.00 ppm for 1H and 13C, respectively and CD3OD at δ = 3.30 ppm and δ = 49.00 ppm for 1H and 13C, respectively, on an Avance 400 Digital NMR spectrometer (Bruker, Rheinstetten, Germany) operating at 400.1 MHz for 1H and 100.6 MHz for 13C. Chemical shifts are reported in δ ppm and coupling constants (J) are given in Hz, multiplicities are reported as follows: singlet (s), doublet (d), doublet of doublets (dd), doublet of triplets (dt), triplet (t), quartet (q), multiplet (m). IR spectra were recorded as KBr disks in a FT-IR 6700 spectrometer (Nicolet, Thermo Scientific, San Jose, CA, USA) and frequencies are reported in cm−1. High-resolution mass spectra (HRMS-ESI) were recorded in a Exactive Plus mass spectrometer (Thermo Scientific, Waltham, MA, USA). The analysis for the reaction products was performed with the following relevant parameters: heater temperature, 50 °C; sheath gas flow, 5 (arbitrary unit); sweep gas flow rate, 0 (arbitrary unit) and spray voltage, 3.0 kV at negative mode. The accurate mass measurements were performed at a resolving power: 140,000 FWHM at range m/z 300–500. Optical rotations were measured on a Model AA-5 polarimeter (Optical Activity, Ltd., NJ, USA) with a sodium lamp using a l = 0.1 dm cell and are reported as follows: [ α ] D ° C (c (g/100 mL), solvent). For analytical TLC, silica gel 60 in 0.25 mm layer was used and TLC spots were detected by heating after spraying with 25% H2SO4 in H2O. Chromatographic separations were carried out by conventional column on silica gel 60 (230–400 mesh) using EtOAc-hexane gradients of increasing polarity. All organic extracts were dried over anhydrous magnesium sulfate and evaporated under reduced pressure, below 40 °C.

3.2. X-ray Crystal Structure Determination

A suitable single crystal of compound 22 was mounted on a MiTeGen MicroMount (MiTeGen, Lansing, NY, USA) in a random orientation. Diffraction data was collected at 120 K on a D8 VENTURE diffractometer (Bruker, Rheinstetten, Germany) equipped with a bidimensional CMOS Photon100 detector, using graphite monochromated Cu-Kα radiation (λ = 1.54178 Å). The diffraction frames were integrated using the APEX2 package. The structure of 22 was solved using Olex2 [51], with the olex2.solve structure solution program using Charge Flipping [52] and refined with full-matrix least-square methods based on F2 (SHELXL) [53]. Non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms were included in their calculated positions, assigned fixed isotropic thermal parameters and constrained to ride on their parent atoms. A summary of the details about crystal data, collection parameters and refinement are documented in Supplementary Material, and additional crystallographic details are in the CIF files. CCDC 1583718 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336033; E-mail: [email protected]. ORTEP view was drawn using OLEX2 software [51].

3.3. Synthesis

3α-Acetoxy-24-nor-5α-cholan-22-en-6-one (20). To a solution of 17 (4.00 g, 9.25 mmol) in dry benzene (150 mL) were added Cu(OAc)2 (0.29 g, 1.60 mmol) and pyridine (1.5 mL). Then, under reflux, Pb(OAc)4 (9.75 g, 22.0 mmol) was added in four portions at hourly intervals. After the addition was completed, the reaction was continued for 1 h. The end of reaction was verified by TLC, and then the mixture was filtered, and the solvent was evaporated under reduced pressure. The crude was re-dissolved in DCM (8 mL) and chromatographed on silica gel with PE/EtOAc mixtures of increasing polarity (19.8:0.2 → 15.8:4.2). Compound 20 (2.67 g, 75% yield) was obtained as a colorless solid: m.p. 64.0–66.1°C (hexane/Et2O = 1/1); [ α ] D 19 = −21.2° (c = 2.36, MeOH); 1H-NMR (CDCl3) δ 5.66 (ddd, J = 17.0; 10.2 and 8.4 Hz, 1H, H-22), 5.12 (m, 1H, H-3), 4.93 (dd, J = 17.0 and 1.8 Hz, 1H, Htrans-23), 4.83 (dd, J = 10.2 and 1.8 Hz, 1H, Hcis-23), 2.56 (dd, J = 12.1 and 3.2 Hz, 1H, H-5), 2.31 (dd, J = 13.1 and 4.5 Hz, 1H, H-7α), 2.04 (s, 3H, CH3CO), 1.04 (d, J = 6.6 Hz, 3H, H-21), 0.748 (s, 3H, H-19), 0.694 (s, 3H, H-18); 13C-NMR (CDCl3) see Table 1; IR νmax: 3082 (CH=CH2); 2946; 2909; 2868 and 2849 (C-H), 1740 (C=O), 1708 (C=O), 1637 (C=C), 1263 (C-O), 1021 (C-O), 988 (CH=CH2), 926 (CH=CH2) cm−1. HRMS-ESI (positive mode): m/z calculated for C25H38O3: 386.2821 [M]+; found 387.2874 [M + H]+.
3α-Acetoxy-22(S), 23-dihydroxy-24-nor-5α-cholan-6-one (21a) and 3α-acetoxy-22(R), 23-dihydroxy-24-nor-5α-cholan-6-one (21b). To a solution of 20 (2.50 g, 6.47 mmol) in acetone (150 mL) was added NMO (0.45 g, 3.84 mmol). Then the mixture was homogenized by magnetic stirring and 2.0 mL of 4% OsO4 (0.210 mmol) was added dropwise with stirring for 36 h at room temperature. The end of the reaction was verified by TLC. Then the solvent was removed (up to 25 mL approximate volume) and water (25 mL) and Na2S2O3·5H2O (25 mL saturated solution) were added. The organic layer was extracted with EtOAc (2 × 30 mL), washed with water (2 × 50 mL), dried over Na2SO4, and filtered. The solvent was evaporated under reduced pressure. The crude was re-dissolved in DCM (10 mL) and chromatographed on silica gel with PE/EtOAc mixtures of increasing polarity (19.8:0.2 → 9.8:10.2). A mixture of 21a/21b = 7.5/1.0 was obtained (1.97 g, 72% yield). Recrystallization of this mixture (MeOH/Et2O = 3/1) allows for compound 21a to be obtained as colorless solid (1.74 g, 64% yield): m.p. 250.1–253.8 °C; [ α ] D 19 = −7.41° (c = 5.40, CHCl3); 1H-NMR (CDCl3) δ 5.11 (m, 1H, H-3), 3.79 (dt, J = 9.6 and 3.6 Hz, 1H, H-22), 3.64 (dd, J = 10.8 and 3.6 Hz, 1H, H-23a), 3.51 (dd, J = 10.8 and 9.6 Hz, 1H, H-23b), 2.55 (dd, J = 12.1 and 3.2 Hz, 1H, H-5), 2.31 (dd, J = 13.1 and 4.5 Hz, 1H, H-7α), 2.03 (s, 3H, CH3CO), 0.954 (d, J = 6.9 Hz, 3H, H-21), 0.735 (s, 3H, H-19), 0.675 (s, 3H, H-18); 13C-NMR (CDCl3) see Table 1; IR νmax: 3519 (O-H), 2941 and 2885 (C-H), 1732 (C=O), 1708 (C=O), 1278 (C-O), 1050 (C-O) cm−1; HRMS-ESI (negative mode): m/z calculated for C25H40O5: 420.2876 [M]+; found 419.2811 [M − H].
3α-Acetoxy-22(S)-hydroxy-24-nor-5α-cholan-6-oxo-23-benzoate (22). Compound 21a (0.5 g, 1.19 mmol) was dissolved in DCM (25 mL) and pyridine (1.0 mL). Later DMAP (5.0 mg) and PhCOCl (0.5 mL, 4.30 mmol) were added with slow stirring at room temperature. The end of the reaction was verified by TLC (2 h), solvent volume was reduced to about 10 mL, and then EtOAc (20 mL) were added. The organic layer was washed with 5% KHSO4 (2 × 5 mL) and water (2 × 10 mL), dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure. The crude was redissolved in DCM (5 mL) and chromatographed on silica gel with PE/EtOAc mixtures of increasing polarity (19.8:0.2 → 14.2:5.8). Compound 22 (0.59 g, 93.8% yield) was obtained as a colorless solid: m.p. 210.5–211.7 °C (MeOH/Et2O = 1/2); [ α ] D 19 = −17.1° (c = 1.75, CHCl3); 1H-NMR (CDCl3) δ 8.05 (d, J = 7.4 Hz, 2H, HAr-2’), 7.58 (t, J = 7.4 Hz, 1H, HAr-4’), 7.46 (t, J = 7.4 Hz, 2H, HAr-3’), 5.12 (m, 1H, H-3), 4.50 (dd, J = 11.4 and 1.7 Hz, 1H, H-23a), 4.20 (dd, J = 11.3 and 4.2 Hz, 1H, H-23b), 4.06 (m, 1H, H-22), 2.57 (dd, J = 12.0 and 2.9 Hz, 1H, H-5), 2.32 (dd, J = 13.1 and 4.5 Hz, 1H, H-7α), 2.04 (s, 3H, CH3CO), 1.06 (d, J = 6.9 Hz, 3H, H-21), 0.748 (s, 3H, H-19), 0.709 (s, 3H, H-18); 13C-NMR (CDCl3) (see Table 1); IR νmax: 3502 (O-H), 2951, 2936, 2893 and 2870 (C-H), 1730 (C=O), 1715 (C=O), 1693 (C=O), 1601 (C=C Ar), 1276 (C-O), 1070 (C-O), 716 (C-H Ar) cm−1; HRMS-ESI (positive mode): m/z calculated for C32H44O6: 524.3138 [M]+; found 525.3186 [M + H]+.
3α-22(S), 23-Trihydroxy-24-nor-5α-cholan-6-one (9). To a solution of 21a (0.5 g, 1.19 mmol) in MeOH (30 mL) was added K2CO3 (0.493 g, 3.57 mmol), then the suspension was stirred at room temperature for 3 h. The end of the reaction was verified by TLC. Then the solvent was removed to dryness and the residue acidified with 2% HCl (20 mL). The obtained solid was filtered and washed with 5% NaHCO3 (20 mL) and water (2 × 10 mL) and dried. Compound 9 (0.437 g, 97% yield) was obtained as a colorless solid: m.p. 227.0–229.1 °C (MeOH/Et2O = 3/1); [ α ] D 19 = −3.67° (c = 2.73, MeOH); 1H-NMR (CD3OD) δ 4.04–4.03 (m, 1H, H-3), 3.71 (dt, J = 8.9 and 3.2 Hz, 1H, H-22), 3.60 (dd, J = 11.3 and 2.7 Hz, 1H, H-23a), 3.40 (dd, J = 11.3 and 8.9 Hz, 1H, H-23b), 2.74 (t, J = 7.9 Hz, 1H, H-5), 2.21 (dd, J = 13.1 and 4.8 Hz, 1H, H-7α), 2.11 (t, J = 13.1 Hz, 1H, H-7α), 2.04 (dt, J = 12.2 and 2.2 Hz, 1H, H-12α), 0.943 (d, J = 6.9 Hz, 3H, H-21), 0.732 (s, 3H, H-19), 0.716 (s, 3H, H-18); 13C-NMR (CD3OD) see Table 1; IR νmax: 3387 (O-H), 2940, 2906 and 2871 (C-H), 1700 (C=O), 1246 (C-O), 1050 (C-O), 754 (CH) cm−1; HRMS-ESI (positive mode): m/z calculated for C23H38O4: 378.2770 [M]+; found 379.2823 [M + H]+.
3α-22(S), 23-Triacetoxy-24-nor-5α-cholan-6-one (23). Compound 21a (2.0 g, 4.76 mmol) was dissolved in DCM (30 mL) and pyridine (3.0 mL). Later DMAP (5.0 mg) and Ac2O (1 mL, 10.6 mmol) were added to the solution and the reaction mixture was stirred at room temperature. The end of the reaction was verified by TLC (30 min), volume of solvent was reduced to about 5 mL and extracted with EtOAc (2 × 10 mL). The organic layer was washed with 5% KHSO4 (2 × 5 mL) and water (2 × 10 mL), dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure. The crude was redissolved in DCM (5 mL) and chromatographed on silica gel with PE/Et2O mixtures of increasing polarity (19.8:0.2 → 11.8:8.2). Compound 23 (2.33 g, 97% yield) was obtained as a colorless solid: m.p. 136.1–137.6 °C (Et2O/hexane); [ α ] D 19 = +2.53° (c = 3.95, CHCl3); 1H-NMR (CDCl3) δ 5.10–5.09 (m, 2H, H-3 and H-22), 4.31 (dd, J = 11.9 and 1.9 Hz, 1H, H-23a), 3.99 (dd, J = 11.9 and 9.4 Hz, 1H, H-23b), 2.54 (dd, J = 12.1 and 3.1 Hz, 1H, H-5), 2.30 (dd, J = 13.1 and 4.4 Hz, 1H, H-7α), 2.06 (s, 3H, AcO), 2.04 (s, 3H, AcO), 2.03 (s, 3H, AcO), 0.973 (d, J = 7.0 Hz, 3H, H-21), 0.723 (s, 3H, H-19), 0.651 (s, 3H, H-18); 13C-NMR (CDCl3) (see Table 1); IR νmax: 2945, 2908 and 2871 (C-H), 1737 (C=O), 1711 (C=O), 1369 (CH3), 1242 (C-O), 1224 (C-O), 1051 (C-O), 757 (C-H) cm−1; HRMS-ESI (positive mode): m/z calculated for C29H44O7: 504.3087 [M]+; found 505.3134 [M + H]+.
3α-22(S), 23-Triacetoxy-24-nor-B-homo-7-oxa-5α-cholan-6-one (24) and 3α-22(S), 23-triacetoxy-24-nor-B-homo-6-oxa-5α-cholan-6-one (25). Preparation of oxidant: 1.0 mL of H2O2 (30%), (9.77 mmol) was slowly dripped into a solution of (CF3CO)2O (1.20 mL, 8.52 mmol) at 0 °C, diluted with CHCl3 (3 mL) and stirred for 30 min. The oxidant mixture (3.0 mL) was slowly added to the solution of compound 23 (1.00 g, 1.98 mmol in 10 mL of CHCl3) at 0 °C and slowly stirred in N2 atmosphere for 24 h. The end of reaction was verified by TLC, the mixture was filtered, then concentrated in a rotary evaporator to a volume of approximately 10 mL. Then Et2O (40 mL) was added and the organic layer was washed with saturated NaHCO3 solution (2 × 20 mL), water (2 × 15 mL), then dried over Na2SO4, and filtered. The solvent was evaporated and the crude was re-dissolved in DCM (5 mL) and chromatographed on silica gel with hexane/Et2O mixtures of increasing polarity (0.2:50.0 → 23.8:26.2). Three fractions were obtained. Fraction I (less polar): 0.363 g (35% yield), compound 24. Fraction II (medium polarity): 0.285 g, mixture of compounds 24 and 25. Fraction III (more polar): 0.146 g (14% yield) compound 25.
Compound 24 was obtained as a colorless solid: m.p. 90.3–91.8 °C (Hexane/Et2O = 2/1); [ α ] D 19 = +50.9° (c = 4.13, CHCl3); 1H-NMR (CDCl3) δ 5.11–5.09 (m, 2H, H-3 and H-22), 4.32 (dd, J = 11.9 and 1.9 Hz, 1H, H-23a), 4.13–4.04 (m, 2H, H-7α and H-7α), 3.99 (dd, J = 11.9 and 9.4 Hz, 1H, H-23b), 3.03 (dd, J = 12.2 and 4.3 Hz, 1H, H-5), 2.08 (ddd, J = 16.2, 12.2 and 2.70 Hz, 1H, H-4α), 2.08 (s, 6H, AcO), 2.05 (s, 3H, AcO), 0.979 (d, J = 6.8 Hz, 3H, H-21), 0.897 (s, 3H, H-19), 0.701 (s, 3H, H-18); 13C-NMR (CDCl3) (see Table 2); IR νmax: 2965, 2946, 2909 and 2872 (C-H), 1735 (C=O), 1438 (C-H), 1368 (CH3), 1242 (C-O), 1182 (C-O), 1052 (C-O), 754 (C-H) cm−1; HRMS-ESI (positive mode): m/z calculated for C29H44O8: 520.3036 [M]+; found 521.3085 [M + H]+.
Compound 25 was obtained as a colorless solid: m.p. 169.9–170.8 °C (Hexane/Et2O = 2/1); [ α ] D 25 = +61.4° (c = 0.44, MeOH); 1H-NMR (CDCl3) δ 5.14–5.09 (m, 2H, H-3 and H-22), 4.46 (dd, J = 11.3 and 5.3 Hz, 1H, H-5), 4.32 (dd, J = 12.0 and 2.0 Hz, 1H, H-23a), 3.99 (dd, J = 12.0 and 9.4 Hz, 1H, H-23b), 2.55–2.43 (m, 2H, H-7α and H-7α), 2.07 (s, 6H, AcO), 2.05 (s, 3H, AcO), 0.971 (d, J = 6.9 Hz, 3H, H-21), 0.901 (s, 3H, H-19), 0.695 (s, 3H, H-18); 13C-NMR (CDCl3) see Table 2; IR νmax: 2965, 2949 and 2871 (C-H), 1743 (C=O), 1736 (C=O), 1725 (C=O), 1445 (C-H), 1368 (CH3), 1258 (C-O), 1239 (C-O), 1225 (C-O), 1044 (C-O), 1022 (C-O), 754 (C-H) cm−1; HRMS-ESI (positive mode): m/z calculated for C29H44O8: 520.3036 [M]+; found 521.3082 [M + H]+.
3α-22(S), 23-Trihydroxy-24-nor-B-homo-7-oxa-5α-cholan-6-one (18). To a solution of 24 (0.15 g, 0.288 mmol) in MeOH (20 mL) was added K2CO3 (0.050 g, 0.307 mmol), then the suspension was stirred at room temperature for 3 h. The end of the reaction was verified by TLC. Then the solvent was removed to dryness and the residue acidified with 2% HCl (10 mL). The obtained solid was filtered and washed with 5% NaHCO3 (20 mL) and water (2 × 10 mL) and dried. Compound 18 (0.098 g, 86% yield) was obtained as a colorless solid: m.p. 91.8–94.5 °C (MeOH/Et2O = 3/1); [ α ] D 19 = +54.2° (c = 2.95, MeOH); 1H-NMR (CDCl3) δ 4.19–4.15 (m, H-3), 4.08–4.07 (m, 2H, H-7α and H-7α), 3.79 (dt, J = 9.3 and 3.1 Hz, 1H, H-22), 3.64 (dd, J = 11.0 and 2.8 Hz, 1H, H-23a), 3.52 (dd, J = 11.0 and 9.4 Hz, 1H, H-23b), 3.17 (dd, J = 12.3 and 4.4 Hz, 1H, H-5), 2.13 (ddd, J = 13.7, 12.4 and 2.7 Hz, 1H, H-4α), 1.98 (dt, J = 12.6 and 3.3 Hz, 1H, H-12α), 0.950 (d, J = 6.9 Hz, 3H, H-21), 0.888 (s, 3H, H-19), 0.710 (s, 3H, H-18); 13C-NMR (CDCl3/CD3OD = 2/1) see Table 2; IR νmax: 3400 (O-H); 2959; 2941; 2902 and 2870 (C-H); 1709 (C=O); 1315 (C-H); 1249 (C-O); 1183 (C-O), 1065 (C-O); 1048 (C-O), 753 (C-H) cm−1; HRMS-ESI (positive mode): m/z calculated for C23H38O5: 394.2719 [M]+; found 395.2771 [M + H]+.
3α-22(S), 23-Trihydroxy-24-nor-B-homo-6-oxa-5α-cholan-6-one (19). Compound 19 was obtained from 25 by the same method described above. Compound 25 (0.15 g, 0.288 mmol), MeOH (20 mL), K2CO3 (0.050 g, 0.307 mmol). Compound 25 (0.092 g, 81% yield), colorless solid: m.p. 227.4–229.5 °C (MeOH/Et2O =3/1); [ α ] D 19 = +27.1° (c = 1.48, MeOH); 1H-NMR (CDCl3) δ 4.60 (dd, J = 11.3 and 5.3 Hz, 1H, H-5), 4.23–4.21 (m, 1H, H-3), 3.79 (dt, J = 9.4 and 3.1 Hz, 1H, H-22), 3.64 (dd, J = 10.9 and 2.6 Hz, 1H, H-23a), 3.50 (dd, J = 10.9 and 9.4 Hz, 1H, H-23b), 2.53–2.43 (m, 2H, H-7α and H-7α), 0.944 (d, J = 6.9 Hz, 3H, H-21), 0.892 (s, 3H, H-19), 0.701 (s, 3H, H-18); 13C-NMR (CDCl3/CD3OD = 2/1) see Table 2; IR νmax: 3386 (O-H); 2942; 2889; 2869 and 2851 (C-H); 1710 (C=O); 1278 (C-O); 1038 (C-O); 751 (C-H) cm−1; HRMS-ESI (negative mode): m/z calculated for C23H38O5: 394.2719 [M]+; found 393.2652 [M − H].

4. Conclusions

A new synthetic route has been used to obtain the known brassinosteroid analog 9 and new compounds 18, 19, 21a, 2225. Compound 9 was obtained from 17 in a total yield of 46%, whereas new lactones analogues 18 and 19 were obtained from glycol 21a in 29% and 11% total yields. Additionally, using 1D, 2D NMR, and HRMS we have achieved full structural determination of all compounds shown in Scheme 1 and Scheme 2. The absolute stereochemistry at position C-22 was established a (S) by X-ray crystallography studies of the benzoylated derivative 22. This conclusion is in line with literature data reported for similar steroidal structures [14]. Finally, in order to establish a relationship between the side chain structure of BRs analogs and the promoting plant growth activity, additional changes on the side chain should be introduced.

Supplementary Materials

The following are available online, X-ray structure of compound 22 (CIF); Spectra 1H and 13C-NMR of compounds 9, 1820, 21a, 2325 (PDF); Spectra HRMS of compounds 9, 1820, 21a, 2325 (PDF).

Author Contributions

R.C. and C.G. carried out the synthesis, separation and purification of compounds. L.E. Project Administration, supervised the whole work, collaborated on the synthesis, structure determination by spectroscopic methods (1D, 2D NMR, HRMS and IR), and manuscript redaction. A.F.O. collaborated in the discussion and interpretation of the results, manuscript redaction and corrections. M.F. collaborated with X-ray crystallography studies.

Funding

This research was funded by FONDECYT (grant No. 1160446) and DGIP-USM (grant No. 116.13.12) of Universidad Técnica Federico Santa María.

Acknowledgments

Rodrigo Carvajal thanks to “Programa de Iniciación a la Investigación Científica (PIIC-2014)” de la Dirección General de Investigación y Postgrado (DGIP-USM) of Universidad Técnica Federico Santa María.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Thompson, M.J.; Meudt, W.J.; Mandava, N.B.; Dutky, S.R.; Lusby, W.R.; Spaulding, D.W. Synthesis of Brassinosteroids and Relationship of Structure to Plant Growth-Promoting Effects. Steroids 1982, 39, 89–105. [Google Scholar] [CrossRef]
  2. Takatsuto, S.; Yazawa, N.; Ikekawa, N.; Morishita, T.; Abe, H. Synthesis of (24R)-28-Homobrassinolide Analogs and Structure Activity Relationships of Brassinosteroids in the Rice-Lamina Inclination Test. Phytochemistry 1983, 22, 1393–1397. [Google Scholar] [CrossRef]
  3. Takatsuto, S.; Yazawa, N.; Ikekawa, N.; Takematsu, T.; Takeuchi, Y.; Koguchi, M. Structure Activity Relationship of Brassinosteroids. Phytochemistry 1983, 22, 2437–2441. [Google Scholar] [CrossRef]
  4. Yokota, T.; Arima, M.; Takahashi, N.; Takatsuto, S.; Ikekawa, N.; Takematsu, T. 2-Deoxycastasterone, a new brassinolide-related bioactive steroid from pinus pollen. Agric. Biol. Chem. 1983, 47, 2419–2420. [Google Scholar] [CrossRef]
  5. Schneider, J.A.; Yoshihara, K.; Nakanishi, K.; Kato, N. Typhasterol (2-deoxycastasterone)—A new plant-growth regulator from cat-tail pollen. Tetrahedron Lett. 1983, 24, 3859–3860. [Google Scholar] [CrossRef]
  6. Abe, H.; Morishita, T.; Uchiyama, M.; Takatsuto, S.; Ikekawa, N. A New Brassinolide-Related Steroid in the Leaves of Thea-Sinensis. Agric. Biol. Chem. 1984, 48, 2171–2172. [Google Scholar] [CrossRef]
  7. Suzuki, Y.; Yamaguchi, I.; Yokota, T.; Takahashi, N. Identification of castasterone, typhasterol and teasterone from the pollen of zea-mays. Agric. Biol. Chem. 1986, 50, 3133–3138. [Google Scholar] [CrossRef]
  8. Brosa, C.; Capdevila, J.M.; Zamora, I. Brassinosteroids: A new way to define the structural requirements. Tetrahedron 1996, 52, 2435–2448. [Google Scholar] [CrossRef]
  9. Brosa, C.; Soca, L.; Terricabras, E.; Ferrer, J.C.; Alsina, A. New synthetic brassinosteroids: A 5 alpha-hydroxy-6-ketone analog with strong plant growth promoting activity. Tetrahedron 1998, 54, 12337–12348. [Google Scholar] [CrossRef]
  10. Iglesias-Arteaga, M.A.; Martinez, C.P.; Manchado, F.C. Spirostanic analogues of castasterone. Steroids 2002, 67, 159–163. [Google Scholar] [CrossRef]
  11. Romero-Avila, M.; de Dios-Bravo, G.; Mendez-Stivalet, J.M.; Rodriguez-Sotres, R.; Iglesias-Arteaga, M.A. Synthesis and biological activity of furostanic analogues of brassinosteroids bearing the 5 alpha-hydroxy-6-oxo moiety. Steroids 2007, 72, 955–959. [Google Scholar] [CrossRef] [PubMed]
  12. Rosado-Abon, A.; de Dios-Bravo, G.; Rodriguez-Sotres, R.; Iglesias-Arteaga, M.A. Synthesis and plant growth promoting activity of polyhydroxylated ketones bearing the 5 alpha-hydroxy-6-oxo moiety and cholestane side chain. Steroids 2012, 77, 461–466. [Google Scholar] [CrossRef] [PubMed]
  13. Tian, W.S.; Zhou, W.S.; Jiang, B.; Pan, X.F. Studies on Steroidal Plant-Growth Regulator 9. The Preparation of 22R-Penta-Nor-Brassinolides and 22S-24,25,26,27,28-Penta-Nor-Brassinolides. Acta Chim. Sinica 1989, 47, 1017–1021. [Google Scholar]
  14. Yang, Y.X.; Zheng, L.T.; Shi, J.J.; Gao, B.; Chen, Y.K.; Yang, H.C.; Chen, H.L.; Li, Y.C.; Zhen, X.C. Synthesis of 5 alpha-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor. Bioorg. Med. Chem. Lett. 2014, 24, 1222–1227. [Google Scholar] [CrossRef] [PubMed]
  15. Espinoza, L.; Cortes, M. Synthesis and biological activities of two new brassinosteroids functionalized in ring C. Bol. Soc. Chil. Quim. 2002, 47, 335–347. [Google Scholar]
  16. Espinoza, L. Synthesis of Four New Brassinosteroids Analogues 11-Oxo-Functionalized on C Ring, with 24-Nor Side Chain and Containing 5â-Cholanic Acid Skeleton. Org. Chem. Curr. Res. 2015, 4, 1–6. [Google Scholar]
  17. Espinoza, L.; Cortes, M. Synthesis and biological activity of brassinosteroids analogues. Bol. Soc. Chil. Quim. 2002, 47, 511–516. [Google Scholar]
  18. Back, T.G.; Blazecka, P.G.; Krishna, M.V. A new synthesis of castasterone and brassinolide from stigmasterol—A concise and stereoselective elaboration of the side-chain from a C-22 aldehyde. Can. J. Chem. 1993, 71, 156–163. [Google Scholar] [CrossRef]
  19. Back, T.G.; Blazecka, P.G.; Krishna, M.V. A concise synthesis of the brassinolide side-chain. Tetrahedron Lett. 1991, 32, 4817–4818. [Google Scholar] [CrossRef]
  20. Back, T.G.; Krishna, M.V. Synthesis of castasterone and formal synthesis of brassinolide from stigmasterol via a selenosulfonation approach. J. Org. Chem. 1991, 56, 454–457. [Google Scholar] [CrossRef]
  21. Zhou, W.S.; Shen, Z.W. Study on the Synthesis of Brassinolide and Related-Compounds 15. Formal Synthesis of Brassinolide Via Stereoselective Sulfenate Sulfoxide Transformation. J. Chem. Soc. Perkin Trans. 1 1991, 2, 2827–2830. [Google Scholar] [CrossRef]
  22. Tsubuki, M.; Keino, K.; Honda, T. Stereoselective synthesis of plant-growth-regulating steroids—Brassinolide, castasterone, and their 24,25-substituted analogs. J. Chem. Soc. Perkin Trans. 1 1992, 2643–2649. [Google Scholar] [CrossRef]
  23. Furuta, T.; Yamamoto, Y. Stereocontrol of three contiguous chiral centers of brassinosteroid side-chain using alpha-alkoxy organoleads. J. Org. Chem. 1992, 57, 2981–2982. [Google Scholar] [CrossRef]
  24. Nakamura, T.; Tanino, K.; Kuwajima, I. Highly stereoselective chelation controlled ene-reaction of 2-(alkylthio)allyl silyl ethers. Tetrahedron Lett. 1993, 34, 477–480. [Google Scholar] [CrossRef]
  25. Brosa, C.; Peracaula, R.; Puig, R.; Ventura, M. Use of dihydroquinidine 9-o-(9′-phenanthryl) ether in osmium-catalyzed asymmetric dihydroxylation in the synthesis of brassinosteroids. Tetrahedron Lett. 1992, 33, 7057–7060. [Google Scholar] [CrossRef]
  26. Hazra, B.G.; Pore, V.S.; Joshi, P.L. Short-step stereoselective synthesis of 2-alpha,3-alpha,22-triacetoxy-23,24-dinor-5-alpha-cholan-6-one—Key intermediate for the preparation of 24(1)-norbrassinolide, dolicholide and dolichosterone. J. Chem. Soc. Perkin Trans. 1 1993, 15, 1819–1822. [Google Scholar] [CrossRef]
  27. Zhou, W.S.; Huang, L.F. Studies on steroidal plant-growth regulator. 25. Concise stereoselective construction of side-chain of brassinosteroid from the intact side-chain of hyodeoxycholic acid—Formal syntheses of brassinolide, 25-methylbrassinolide, 26,27-bisnorbrassinolide and their related-compounds. Tetrahedron 1992, 48, 1837–1852. [Google Scholar]
  28. Zhou, W.S.; Huang, L.F.; Sun, L.Q.; Pan, X.F. Studies on Steroidal Plant-Growth Regulator. 21. A Stereoselective Construction of Brassinosteroid Side-Chain—A New Practical Synthesis of Brassinolide and Its Analogs. Tetrahedron Lett. 1991, 32, 6745–6748. [Google Scholar] [CrossRef]
  29. Zhou, W.S.; Huang, L.F.; Sun, L.Q.; Pan, X.F. Studies on A Steroidal Plant-Growth Regulator. Part 26. Stereoselective Construction of the Brassinolide Side-Chain: New Practical Syntheses of Brassinolide Analogs from Hyodeoxycholic Acid. J. Chem. Soc. Perkin Trans. 1 1992, 15, 2039–2043. [Google Scholar] [CrossRef]
  30. Huang, L.F.; Zhou, W.S.; Sun, L.Q.; Pan, X.F. Studies on steroidal plant-growth regulators. Part 29. Osmium tetroxide-catalyzed asymmetric dihydroxylation of the (22E,24R) and the (22E,24S)-24-alkyl steroidal unsaturated side-chain. J. Chem. Soc. Perkin Trans. 1 1993, 14, 1683–1686. [Google Scholar] [CrossRef]
  31. Hazra, B.G.; Joshi, P.L.; Bahule, B.B.; Argade, N.P.; Pore, V.S.; Chordia, M.D. Stereoselective synthesis of (22r,23r,24s)-3-beta-hydroxy-5-ene-22,23-dihydroxy-24-methyl-cholestane—A brassinolide intermediate from 16-dehydropregnenolone acetate. Tetrahedron 1994, 50, 2523–2532. [Google Scholar] [CrossRef]
  32. Bacha, J.D.; Kochi, J.K. Alkenes from acids by oxidative decarboxylation. Tetrahedron 1968, 24, 2215–2216. [Google Scholar] [CrossRef]
  33. Vaydia, A.S.; Dixit, S.M.; Rao, A.S. Degradation of bile acid side chain with lead tetraacetate. Tetrahedron 1968, 50, 5173–5174. [Google Scholar] [CrossRef]
  34. Zhou, W.S.; Tian, W.S. Studies on Steroidal Plant-Growth Hormones. 2. Stereoselective Synthesis of (22S, 23S)-Typhasterol from Hyodeoxycholic Acid. Acta Chim. Sinica 1985, 43, 1060–1067. [Google Scholar]
  35. Zhou, W.S.; Jiang, B.; Pan, X.F. Stereoselective Synthesis of the Brassinolide Side-Chain—Novel Syntheses of Brassinolide and Related-Compounds. Tetrahedron 1990, 46, 3173–3188. [Google Scholar] [CrossRef]
  36. Wada, K.; Marumo, S. Synthesis and Plant Growth-Promoting Activity of Brassinolide Analogs. Agric. Biol. Chem. 1981, 45, 2579–2585. [Google Scholar]
  37. Takatsuto, S.; Yazawa, N.; Ishiguro, M.; Morisaki, M.; Ikekawa, N. Stereoselective Synthesis of Plant Growth-Promoting Steroids, Brassinolide, Castasterone, Typhasterol, and Their 28-Nor Analogs. J. Chem. Soc. Perkin Trans. 1 1984, 139–146. [Google Scholar] [CrossRef]
  38. Takatsuto, S. Synthesis of teasterone and typhasterol, brassinolide-related steroids with plant-growth-promoting activity. J. Chem. Soc. Perkin Trans. 1 1986, 1833–1836. [Google Scholar] [CrossRef]
  39. Takatsuto, S.; Ikekawa, N. Synthesis of homodolichosterone and related 2-deoxysteroids. Chem. Pharm. Bull. 1987, 35, 829–832. [Google Scholar] [CrossRef]
  40. Takatsuto, S.; Ikekawa, N.; Morishita, T.; Abe, H. Structure Activity Relationship of Brassinosteroids with Respect to the A/B-Ring Functional-Groups. Chem. Pharm. Bull. 1987, 35, 211–216. [Google Scholar] [CrossRef]
  41. Zhou, W.S.; Tian, W.S. Study on the Synthesis of Brassinolide and Related-Compounds. 3. Stereoselective Synthesis of Typhasterol from Hyodeoxycholic Acid. Tetrahedron 1987, 43, 3705–3712. [Google Scholar] [CrossRef]
  42. Aburatani, M.; Takeuchi, T.; Mori, K. Facile Syntheses of Brassinosteroids: Brassinolide, Castasterone, Teasterone and Typhasterol. Agric. Biol. Chem. 1987, 51, 1909–1913. [Google Scholar] [CrossRef]
  43. Huang, L.F.; Zhou, W.S. Studies on Steroidal Plant-Growth Regulators. Part 33. Novel Method for Construction of the Side-Chain of 23-Arylbrassinosteroids Via Heck Arylation and Asymmetric Dihydroxylation As Key Steps. J. Chem. Soc. Perkin Trans. 1 1994, 3579–3585. [Google Scholar] [CrossRef]
  44. Schmidt, J.; Voigt, B.; Adam, G. 2-Deoxybrassinolide—A naturally-occurring brassinosteroid from apium-graveolens. Phytochemistry 1995, 40, 1041–1043. [Google Scholar] [CrossRef]
  45. Voigt, B.; Schmidt, J.; Adam, G. Synthesis of 24-epiteasterone, 24-epityphasterol and their B-homo-6a-oxalactones from ergosterol. Tetrahedron 1996, 52, 1997–2004. [Google Scholar] [CrossRef]
  46. Herrera, H.; Carvajal, R.; Olea, A.F.; Espinoza, L. Structural modifications of deoxycholic acid to obtain three known brassinosteroid analogues and full NMR spectroscopic characterization. Molecules 2016, 21, 1139. [Google Scholar] [CrossRef] [PubMed]
  47. Ishiguro, M.; Kajikawa, A.; Haruyama, T.; Ogura, Y.; Okubayashi, M.; Morisaki, M.; Ikekawa, N. Synthetic studies of withanolides. Part 1. Synthesis of 5,6beta-epoxy-4beta-hydroxy-5beta-cholest-2-en-1-one and related compounds. J. Chem. Soc. Perkin Trans. 1 1975, 2295–2302. [Google Scholar] [CrossRef]
  48. Parsons, S.; Flack, H.D.; Wagner, T. Use of intensity quotients and differences in absolute structure refinement. Acta Cryist. B 2013, 69, 249–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Hooft, R.W.W.; Straver, L.H.; Spek, A.L. Determination of absolute structure using Bayesian statistics on Bijvoet differences. J. Appl. Crystallogr. 2008, 41, 96–103. [Google Scholar] [CrossRef] [PubMed]
  50. Takatsuto, S.; Ikekawa, N. Remote Substituent Effect on the Regioselectivity in the Baeyer-Villiger Oxidation of 5-Alpha-Cholestan-6-One Derivatives. Tetrahedron Lett. 1983, 24, 917–920. [Google Scholar] [CrossRef]
  51. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  52. Bourhis, L.J.; Dolomanov, O.V.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment-Olex2 dissected. Acta Cryst. A 2015, 71, 59–75. [Google Scholar] [CrossRef] [PubMed]
  53. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Cryst. A 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: Samples of the compounds 9, 1720, 21a, 2225 are available from the authors.
Figure 1. Structure of brassinolide (1), castasterone (2) and typhasterol (3).
Figure 1. Structure of brassinolide (1), castasterone (2) and typhasterol (3).
Molecules 23 01306 g001
Figure 2. Synthetic 24-nor-22(S),23-dihydroxy analogs 516.
Figure 2. Synthetic 24-nor-22(S),23-dihydroxy analogs 516.
Molecules 23 01306 g002
Figure 3. New 2-deoxybrassinosteroids analogs (18 and 19) with 3α-hydroxy-24-nor-22,23-dihydroxy-5α-cholestane side chain type.
Figure 3. New 2-deoxybrassinosteroids analogs (18 and 19) with 3α-hydroxy-24-nor-22,23-dihydroxy-5α-cholestane side chain type.
Molecules 23 01306 g003
Scheme 1. Synthesis of compound 21a, followed by selective benzoylation at the C-23 position to obtain the derivative 22, and synthesis of brassinosteroid analog 9. CC stands for Column Chromatography.
Scheme 1. Synthesis of compound 21a, followed by selective benzoylation at the C-23 position to obtain the derivative 22, and synthesis of brassinosteroid analog 9. CC stands for Column Chromatography.
Molecules 23 01306 sch001
Figure 4. ORTEP diagram of derivative 22 showing full atom-numbering scheme. Thermal ellipsoids are drawn at the 50% probability level.
Figure 4. ORTEP diagram of derivative 22 showing full atom-numbering scheme. Thermal ellipsoids are drawn at the 50% probability level.
Molecules 23 01306 g004
Scheme 2. Synthesis of triacetylated derivative 23 and its subsequent Baeyer-Villiger oxidation to obtain new 2-deoxybrassinosteroids 18 and 19.
Scheme 2. Synthesis of triacetylated derivative 23 and its subsequent Baeyer-Villiger oxidation to obtain new 2-deoxybrassinosteroids 18 and 19.
Molecules 23 01306 sch002
Figure 5. Inverse detection heteronuclear-correlated 2D 1H-13C HMBC contour plot, and main 2JHC (red) and 3JHC (blue) correlations observed for hydrogens H-5α and H-7 of compound 24 (7-oxalactone).
Figure 5. Inverse detection heteronuclear-correlated 2D 1H-13C HMBC contour plot, and main 2JHC (red) and 3JHC (blue) correlations observed for hydrogens H-5α and H-7 of compound 24 (7-oxalactone).
Molecules 23 01306 g005
Figure 6. Inverse Detection Heteronuclear-Correlated 2D 1H-13C HMBC Contour Plot, and Major 2JHC (red) and 3JHC (blue) Correlations Observed for Protons H-5α and H-7 of Compound 25 (6-oxalactone).
Figure 6. Inverse Detection Heteronuclear-Correlated 2D 1H-13C HMBC Contour Plot, and Major 2JHC (red) and 3JHC (blue) Correlations Observed for Protons H-5α and H-7 of Compound 25 (6-oxalactone).
Molecules 23 01306 g006
Figure 7. Major differences between chemical shift of hydrogens H-5 and H-7. Partial 1H-NMR spectra (1.85–5.00 ppm) of lactones 2-Deoxybrassinosteroids 18 (bottom) and 19 (top).
Figure 7. Major differences between chemical shift of hydrogens H-5 and H-7. Partial 1H-NMR spectra (1.85–5.00 ppm) of lactones 2-Deoxybrassinosteroids 18 (bottom) and 19 (top).
Molecules 23 01306 g007
Table 1. δ(ppm) 13C-NMR (CDCl3, 100.6 MHz) for compounds 20, 21a, 22, and 9.
Table 1. δ(ppm) 13C-NMR (CDCl3, 100.6 MHz) for compounds 20, 21a, 22, and 9.
C2021a229 *
132.3832.1732.3632.88
228.1927.2027.4128.73
368.8568.7068.8166.02
425.2725.0525.2628.53
552.5852.3852.5852.84
6211.81211.72211.62214.49
746.7546.4946.6947.61
837.9237.7437.9039.45
953.7952.6852.9054.19
1041.2841.0741.2342.62
1121.0620.8721.0622.19
1239.3639.1939.4140.76
1342.9443.1643.4144.46
1455.4153.5153.7255.08
1525.0124.7825.0028.45
1623.9123.8524.0225.07
1756.8056.1556.4157.56
1812.1811.5611.8112.14
1912.4112.2012.4012.67
2041.1039.8740.3342.01
2120.0412.8612.9013.42
22144.8973.6971.7775.19
23111.8462.2266.3963.19
CH3CO170.26170.15170.27-
CH3CO21.4121.2121.41-
CH3CO----
CH3CO----
CH3CO----
CH3CO----
COAr--167.01-
1’--129.86-
2’--129.63-
3’--128.45-
4’--133.22-
* The 13C-NMR spectrum of compound 9 was recorded in MeOD solution.
Table 2. δ(ppm) 13C-NMR (CDCl3, 100.6 MHz) for compounds 18, 19, 2325.
Table 2. δ(ppm) 13C-NMR (CDCl3, 100.6 MHz) for compounds 18, 19, 2325.
C23242518 *19 *
132.3533.6631.8432.7831.06
227.0126.9526.6524.8425.25
368.7968.3869.5664.3265.60
425.2429.7432.9532.5035.39
552.5542.5779.6841.6780.04
6211.49175.97174.64177.44176.08
746.6370.3138.1270.4337.88
837.8539.4238.3139.5439.89
952.8458.3157.9758.1557.77
1041.1836.1439.5536.1739.64
1121.0322.1022.1722.0322.02
1239.3839.5339.6940.0339.48
1343.3943.0343.0942.9142.91
1453.6752.8055.1352.7054.94
1524.9825.1325.3327.8727.46
1623.9424.8324.8327.2026.76
1756.3751.1053.1450.9852.97
1811.8111.5711.5911.4111.32
1912.3814.5411.5914.3911.32
2038.3238.3234.7839.3334.77
2113.3713.2813.2912.7712.66
2273.9773.8073.8073.5773.50
2362.3962.3062.3562.0862.02
CH3CO171.09171.07171.12--
CH3CO21.3921.3621.32--
CH3CO170.42170.40170.41--
CH3CO21.2321.2121.24--
CH3CO170.25170.28170.17--
CH3CO20.8620.8520.88--
* The 13C-NMR spectrum of compound 18 and 19 were recorded in CDCl3/MeOD 2/1, solution.

Share and Cite

MDPI and ACS Style

Carvajal, R.; González, C.; Olea, A.F.; Fuentealba, M.; Espinoza, L. Synthesis of 2-Deoxybrassinosteroids Analogs with 24-nor, 22(S)-23-Dihydroxy-Type Side Chains from Hyodeoxycholic Acid. Molecules 2018, 23, 1306. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23061306

AMA Style

Carvajal R, González C, Olea AF, Fuentealba M, Espinoza L. Synthesis of 2-Deoxybrassinosteroids Analogs with 24-nor, 22(S)-23-Dihydroxy-Type Side Chains from Hyodeoxycholic Acid. Molecules. 2018; 23(6):1306. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23061306

Chicago/Turabian Style

Carvajal, Rodrigo, Cesar González, Andrés F. Olea, Mauricio Fuentealba, and Luis Espinoza. 2018. "Synthesis of 2-Deoxybrassinosteroids Analogs with 24-nor, 22(S)-23-Dihydroxy-Type Side Chains from Hyodeoxycholic Acid" Molecules 23, no. 6: 1306. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules23061306

Article Metrics

Back to TopTop